Future & Tech,
dedicated to innovation that enriches human happiness and quality of life.
Improving human
happiness and
quality of life
Scroll Down
At Future & Tech,
We are committed to ensuring human health and the environment
with next-generation active immunotherapy.
Future & Tech develops immune therapeutics for various human diseases based on our proprietary technology,
while collaborating with the industrial animal phamaceutical sector to develop and obtain regulatory approvals and certifications
for microorganism-based veterinary medicines for industrial animals.
GRAS μ-Organism Surface-display Technique
GRAS (GRAS μ-Organism Surface-display Technique)
A technology that recombines a linker-connected target antigen gene
to the gene of the motif membrane protein present on the cell surface of lactic acid bacteria,
enabling chimeric expression of the gene on the microbial surface.
Selective media,
Temperatures,
Oxygen tensions,
Microorganisms for commensalism -
Isolates
Combination
STOM-IC (Selective media, Temperatures, Oxygen tensions, Microorganisms and Isolates Combination for commensalism) Isolation and Cultivation Technology for Unculturable Microorganisms
More View +Development of next-generation immunotherapeutics
using GOSTα technology.
You can scroll left and right to view the full content.
| Pipeline | Development Projects | Target diseases | Development of drug candidate | Preclinical trials | Safety test | Clinical trial - phase 1 | Clinical trial - phase 2 |
|---|---|---|---|---|---|---|---|
| FT005 | FT005-002 (Hulk) | Chronic kidney disease |
|
||||
| Sarcopenia (muscle atrophy with aging) | |||||||
| Muscular dystrophy | |||||||
| FT006 | FT006-001 (Batman) | COVID prevention | |||||
| FT007 | FT005-002 (Hulk) | Cancer cachexia | |
||||
| FT005-007 (Steve) | |
||||||
| FT009 | FT005-002 (Hulk) | Type 2 diabetes | |
||||
| FT011 | FT005-005 (Paul) | Melanoma (skin cancer) | |
||||
| FT012 | FT005-004 (Kyte) | Melanoma (skin cancer) | |
| Pipeline | Development Projects | Target diseases | Development of drug candidate | Preclinical trials | Safety test | Field trials | Product approval |
|---|---|---|---|---|---|---|---|
| vFT001 | FT005-002 (MyoLac II) |
Industrial animal improvements | |||||
| vFT005 | |||||||
| vFT011 | FT005-005 (Lobster) |
Melanoma, Lymphoma |
|||||
| vFT012 | FT005-004 (Crab) |
Osteosarcoma, Mast cell tumors, Mammary tumors |